Sponsor pipeline

Elpida Therapeutics SPC clinical trial pipeline

Get alerts when Elpida Therapeutics SPC's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1/2
2
Phase 3
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06692712 Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls. Hereditary Spastic Paraplegia Type 50 Recruiting 2026-04-20
Phase 1/2
NCT07447557 Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) Charcot-Marie-Tooth Disease Type 4J Recruiting 2026-09-09
NCT05518188 Melpida: Recombinant Adeno-associated Virus (Serotype 9) Encoding a Codon Optimized Human… Spasticity, Muscle Recruiting 2026-07-08
Not specified
NCT06151600 A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth… Peripheral Neuropathy Active, Not Recruiting 2026-07-08
Get alerts when Elpida Therapeutics SPC's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free